Brief: PHAXIAM Provides Update On Deployment Of Strategy To Maximize Development Potential Of Phage Therapy
Jan 31 (Reuters) - Phaxiam Therapeutics SA PHXM.PA :
* PHAXIAM PROVIDES AN UPDATE ON THE DEPLOYMENT OF ITS
STRATEGY TO
MAXIMIZE THE DEVELOPMENT POTENTIAL OF PHAGE THERAPY
* PHAXIAM THERAPEUTICS SA - ACCELERATES IPT MODEL DEPLOYMENT
WITH
TECHNOPHAGE COLLABORATION
Source text: ID:nBw88G0xWa
Further company coverage: PHXM.PA
((Reuters.Briefs@thomsonreuters.com))
Recent news on Phaxiam Therapeutics SA
See all newsBrief: Phaxiam Therapeutics Announces The Suspension Of Trading In Its Shares Until Delisting
Brief: Phaxiam Therapeutics Announces Judicial Liquidation And Delisting
Brief: Phaxiam Therapeutics Says Postponement Of The Offer Review Hearing
Brief: Phaxiam Therapeutics Announces Launch Of Process To Find Buyers In Context Of Its Receivership Procedure
Brief: Phaxiam Therapeutics Says Commercial Court Of Lyon To Open Judicial Receivership Procedure